Series B funding round for Delfi Diagnostics raising $230M in July 2022
Series B funding round for Delfi Diagnostics raising $230M in July 2022
| Investor | Firm Type | Partner |
|---|
DFJ GrowthLEAD | Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Eli Lilly |
| Angel | Scott Hartley |
| Angel | Jenny Fielding |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Delfi Diagnostics raised $230M in a Series B round.
The round was announced on 07/01/22.
The round was led by Justin Kao.